Podcasts about downstate medical center

*What if those diagnosed with Alzheimer's Disease could still expect years of meaningful life? *How can we lessen the unfair and damaging stigma around this illness? Join Jennifer Reid, MD as she interviews Dr. Gayatri Devi, MD, neurologist and author of The Spectrum of Hope: An Optimistic and New Approach to Alzheimer's Disease and other Dementias. Dr. Gayatri Devi has focused her entire career on promoting brain health and quality of life in neurologic disease. She is board-certified in Neurology, Pain Medicine, Psychiatry, and Brain Injury Medicine as well as Behavioral Neurology and Neuropsychiatry.Dr. Gayatri's website: https://nybrain.org/Jennifer Reid, MD: thereflectivedoc.comDiscussed in this Episode:1) The harmful myths about disease course in Alzheimer's 2) Proper diagnosis of dementia, and why it is so often missed in doctors' offices3) New, effective treatments for slowing disease progression4) How women and men respond differently to a dementia diagonsisDr. Devi is currently the director of Park Avenue Neurology and an Attending Physician at Lenox Hill Hospital | Northwell Health as well as a Clinical Professor of Neurology at Downstate Medical Center. Her research focuses on the optimal treatment of stroke, cognitive loss, and pain.Dr. Devi has been featured in multiple news outlets, including the BBC, NY Times and Wall Street journal, and has written several books. She is neurologic consultant to the NY State Committee for Physician Health and the NFL Players Association. Born and raised in India, the daughter, granddaughter, and great-granddaughter of physicians, Dr. Devi continues a tradition of caring that began 140 years ago.Seeking a mental health provider? Try Psychology TodayNational Suicide Prevention Lifeline: 1-800-273-8255SAMHSA's National Helpline - 1-800-662-HELP (4357)Dial 988 for Mental Health EmergencyThoughts and opinions expressed on show are those of host and guests, and not associated with any academic institution.Disclaimer:The information and other content provided on this podcast or in any linked materials, are not intended and should not be construed as medical advice, nor is the information a substitute for professional medical expertise or treatment. All content, including text, graphics, images and information, contained on or available through this website is for general information purposes only.If you or any other person has a medical concern, you should consult with your health care provider or seek other professional medical treatment. Never disregard professional medical advice or delay in seeking it because of something that have read on this website, blog or in any linked materials. If you think you may have a medical emergency, call your doctor or emergency services (911) immediately. You can also access the National Suicide Help Line aThe Reflective DocWebsite - Instagram - Facebook - Linked In - Twitter - Think Like a Shrink Blog on Psychology Today

In this week's episode, we take a look at the mysterious and deceptive world of psychics. Part 1: Rich Tackenberg is skeptical when a psychic tells him there's something wrong with his car. Part 2: Science journalist Katherine J. Wu interviews neuroscientists Susana Martinez-Conde and Stephen Macknik to get a better idea of how psychics, like the one from Rich Tackenberg's story, operate. Rich Tackenberg is: a happily married gadget geek, a new homeowner, an SNL apologist, an Apple fanboy, a recent convert to tea, a dog owner, a recovering people-pleaser, a comedy nerd, an LA resident, a New York native, a snob about disposable pens, and (most importantly) a big fan of lists.  Susana Martinez-Conde and Stephen Macknik are award-winning neuroscientists and professors at the State University of New York, Downstate Medical Center. They are best known for their studies on perception, illusions, and attentional misdirection in stage magic. They produce the annual Best Illusion of the Year Contest, now in its 13th edition, and are the authors of the international bestseller Sleights of Mind: What the Neuroscience of Magic Reveals About Our Everyday Deceptions and Champions of Illusion: The Science Behind Mind-Boggling Images and Mystifying Brain Puzzles. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Age is a main factor when determining cancer care. In this ASCO Education podcast we speak to one of the top leaders in treatment for older patients who has also credited mentorship as a foundation for his career. Dr. Hyman Muss describes his childhood in Brooklyn, serving as a general physician for troops in Vietnam (6:18), the doctor who influenced his choice of hematology and oncology (7:48) and creating one of the first geriatric oncology fellowships in in the country (21:58).  Speaker Disclosures Dr. David Johnson: Consulting or Advisory Role – Merck, Pfizer, Aileron Therapeutics, Boston University Dr. Patrick Loehrer: Research Funding – Novartis, Lilly Foundation, Taiho Pharmaceutical Dr. Hyman Muss: None More Podcasts with Oncology Leaders  Oncology, Etc. – Devising Medical Standards and Training Master Clinicians with Dr. John Glick Oncology, Etc. – Rediscovering the Joy in Medicine with Dr. Deborah Schrag (Part 1) Oncology, Etc. – In Conversation with Dr. Richard Pazdur (Part 1) If you liked this episode, please follow the show. To explore other educational content, including courses, visit education.asco.org. Contact us at education@asco.org. TRANSCRIPT Pat Loehrer: Welcome to Oncology, Etc., an ASCO Education Podcast. I'm Pat Loehrer, director of Global Oncology and Health Equity at Indiana University.  Dave Johnson: And I'm Dave Johnson of Medical Oncology at the University of Texas Southwestern in Dallas, Texas. If you're a regular listener to our podcast, welcome back. If you're new to Oncology, Etc., the purpose of our podcast is to introduce listeners to interesting and inspirational people and topics in and outside the world of Oncology. We have an inspirational guest today. Pat?  Pat Loehrer: If you ask anyone who's achieved any level of success and how they've achieved it, most likely they'll mention a number of people who've influenced them along the way. Quite often, these people reflect on their mentors, and after a certain time of accomplishment and reflection, they begin to mentor others. This is very much what our next guest has done. Dr. Hyman Muss has been a mentor to me and to Dave, and he's one of the most outstanding, wonderful people in the world, and we're so excited to have him today.   Dr. Hyman Muss served in the US Army in Vietnam, where he was awarded the Bronze Star Medal. He's an experienced Clinician Scientist, the Mary Jones Hudson Distinguished Professor of Geriatric Oncology at the University of North Carolina School of Medicine, and the Director of Geriatric Oncology Program at the UNC Lineberger Comprehensive Cancer Center Program. His interest in education and research is focused on cancer and older patients, and he is internationally recognized in this area. He's been the co-chair of the Alliance Committee on Cancer and Older Adults and won the BJ Kennedy Award from ASCO in Geriatric Care. His particular interest in research expertise is in the care of breast cancer patients, with a focus on the management of women who are of older ages. He's had a major interest in breast cancer survivorship and long-term toxicity of treatment and also served as the co-chair of the Breast Committee for the Alliance Group. He serves as a mentor for medical students, medical residents, junior faculty, and more recently, his Geriatric Oncology fellows. He served on the Board of Directors of the ASCO Foundation and on the ABIM, the American Board of Internal Medicine, where both Dave and I were privileged to work with him and witness his leadership and his deep breadth of knowledge.  Dr. Muss, thanks for joining us today. Dr. Hyman Muss: What a pleasure to be here. Thank you so much for inviting me. My mother would have loved the introduction.  Pat Loehrer: Well, speaking of that, tell us a little bit. You grew up in Brooklyn, so tell us a little bit about your parents. Your father was a dentist, I think, and your uncle was a general practitioner. So give us a little bit of the early life of Hy Muss. Dr. Hyman Muss: So I grew up in Brooklyn, New York. I was born and bred there. I went to Brooklyn Technical High School. I almost went to Brooklyn College, but I came back and went to Downstate Medical Center, which was just terrific. My tuition was $600 a year, but that's another story. My parents lived in the same neighborhood. My dad was a dentist, so we knew all the people. My uncle was the GP. You came into their office, sat down, and they saw you anytime, day or night, almost 24/7, something we're probably not going back to, but they had a profound influence on me. My uncle, as a GP, used to take me on house calls in Brooklyn when they were done, and he had an old Buick with MD plates. And I would go into these families, and they loved him, and they would give me ice cream and things. Maybe that's what made me a doctor. But it was a terrific and indelible experience. I had terrific parents. In those days, doctors and medical people usually lived in the same neighborhoods as their patients, so they really knew their people well. It was a terrific upbringing. I got to love medicine and have never had a look back. Dave Johnson: So your inspiration for a career in medicine obviously started at home. Tell us more about your formal education. You mentioned your high school education. What about college? And shortly thereafter?  Dr. Hyman Muss: Yeah, well, I went to Lafayette College. I was not the best high school student, but I had good college board scores or whatever they called them then. And I went to Lafayette and I thought I was going to be a chemist, a chemistry major. But I took enough premed courses and I spent a summer in a lab building cyclic ketones. And everybody was outside sitting on the lawn of the campus. And I was in there with all these distillation apparatus, and I said, “I don't think I can do this the rest of my life.” So I applied to medical school, and I got into several medical schools. But my father at that time was dying of metastatic bladder cancer. He had been a heavy smoker, and he was still working as a dentist. He worked until the day he unfortunately died. But I got into Downstate. We lived in Brooklyn, and my uncle, the GP, said, "Hy, you need to come home and help take care of your dad." I'm an only child, so I did. And I had a wonderful experience at Downstate.   Several years ago, I was listening to NPR and heard that one of my professors had won the Nobel Prize. Dr. Furchgott in physiology, one would have never thought. And I had a wonderful education and subsequently got into what was then Peter Bent Brigham in Boston, did my internship and residency there, joined the army and medical school, so I wasn't drafted, it was a program then. And then after first year of residency, I went to Vietnam, worked with an artillery battalion, a mystical experience, but no regrets. And then subsequently came back and did hematology and oncology at Brigham and at what was then the Jimmy Fund and Sidney Farber Cancer Center. And Tom Frei had just come. And I did hematology with a guy named Bill Moloney in Boston at Harvard. I'll tell you, a wonderful man. He was like a surrogate father. My dad had died by then, and I just feel I've had every opportunity to have a wonderful education and terrific mentors along the way. Dave Johnson: So we want to ask you about both of those gentlemen, but I would like to just, if I may, drop back to your experience in Vietnam. What was that like?  Dr. Hyman Muss: Well, I was 27 years old and I was put as the doctor for 500 men in artillery. My job was to take care of the general health of the troops. Fortunately, we didn't have many casualties. It wasn't a front war like my uncle, who was a GP actually in World War II, landed in Normandy about a week later and went all through World War II as a doctor. But Vietnam was an unusual war, there wasn't really a front. So my experience was I would go out to fire bases, which were units of about 100 men in the jungle, go out three days in a week in a helicopter, do sick call, check people. I dealt with really alcohol problems, unfortunately, a lot of drug problems. You had young people with really not a lot to do during the day, nothing much to do, and no real goal of being there. I did that for a while, and actually, the reason I got the Bronze Star was because I set up– It was nothing like standing in front of a machine gun. I'm not that kind of brave guy, but I set up a drug amnesty program so I got a lot of support from our regular field people to do this, so we didn't have to keep sending kids home with dishonorable discharges. And I learned a lot. I think we were reasonably successful. I learned a lot about artillery. I think overall it was a great experience in my life. Dave Johnson: Tell us how your interest in hematology and oncology originated. Where did that come from?  Dr. Hyman Muss: When I was an intern at the Brigham, Dr. Moloney was a very famous Harvard professor. He had studied war casualties after Hiroshima, he was one of the people that found the Philadelphia chromosome in CML. He was a guy that rounded on every single one of his leukemia patients every day. So I was an intern. So in those days I would go and see all the hematology people rounding because all the acute leukemia patients and all the serious cancer patients were right on the floors, right on the wards. We had 17-bed wards, and then we had some private rooms. And he loved what he did. And before I left for Vietnam, we didn't have Ara C and daunomycin. So every leukemia patient I saw died. This is '68 to '70. Yet we tried all these different regimens. Occasionally you got someone who did well for six months, a year. But his bedside manner was absolutely wonderful to me. He knew all the patients. He'd ask them about where they lived in Boston. His humanism was terrific, and yet I loved the diseases he treated. The stakes were high. We didn't have good treatment, and I decided that that's probably what I want to do.   So when I was in Vietnam, I applied and got back in the Hematology Fellowship and came back and did that. I saw Ara C and daunomycin. I gave the chemotherapy to them, and he'd say, "Go up and treat Harry Smith with Ara C and daunomycin." I had the syringes in my pocket, guys. Forget about hoods and mixing. And I'd go up and treat them and the marrow would be gone within four or five days. I did a bone marrow. They published their regimen in the New England Journal called COD, C-O-D because they also gave vincristine. So it was cytarabine, vincristine, and daunomycin, the COD regimen. It fit Boston. And I saw it was like the emergence of cisplatin after Larry Einhorn. You saw people that never survived going into remission and I saw some remissions in AML and it cemented it.  About my second year of residency, we had a child. I was running out of money. I was being paid $6,000 a year and I had the GI Bill. I went into Dr. Moloney and he talked with Dr. Franny Moore, who was head of surgery at the Brigham, and they made me the Sidney Farber Research Fellow, doubled my salary and I had to go to the Jimmy Fund and see cancer patients. And it so happened that was when Tom Frei came to Dana-Farber. And so I started rounding with Dr. Frei and seeing those patients. And I think the first day I walked in, I knew I wanted to do more than just leukemia because I saw groups of patients with every disease. We treated everybody with CMFEP, it didn't matter what cancer they had. And I just loved it and said, "My God, there's so much we can learn. What a great career." And so that got me into the oncology portion.   And then I was offered to stay at Harvard. They were going to make me an assistant professor, but they wanted me to do lab work. And I knew my personality, it just wasn't for me. I worked with a lovely guy named Frank Bunn, one of the world's great hem guys in his lab, and he's still a close friend in his 80s. And he told me one day, he said, "Hy, I don't think the lab is for you." And he actually helped me get my first job at Wake Forest University, which turned out to be wonderful. So that's how I ended up with my circuitous in HemOnc. And it's really from great mentors, it's from Bill Moloney, it's from Tom Frei, Dave Rosenthal, tons of wonderful people along the way that not only taught me a lot, but they seemed to love what they do, which is a gift in life to love what you do and love the people you're doing it with. They instilled that in me. Pat Loehrer: From there you went to Wake Forest and there's a couple of colleagues down there, I believe, that inspired you, Charlie Spurr and Bill Hazzard, who was the founding founder of geriatrics. Tell us about that experience and how'd that shape your life.  Dr. Hyman Muss: I was looking for a clinical job and I looked at Rochester, and I got snowed in one night in Wake Forest, and I said, “Where's the contract?” And I signed it. And my mother, who was living in New York City, didn't know where North Carolina was. My mother was from a family, was born over a candy store in Greenwich Village, and said, “Where are you going?” And then I showed her where it was, and she says, “They're going to kill you down there.” And it turned out to be one of the best decisions of my life. My wife Loretta, who both of you know so well, we got out of our VW with our dog and our daughter when we moved here, and VW bug, by the way, not a van, and she cried. It turned out it was one of the best opportunities.  Charlie Spurr was an iconic oncology leader. He actually did some of the early work on nitrogen mustard in Chicago during the war, the first chemotherapy drug. He was a terrific leader. He had patients programmed in on those IBM punch cards. He had little cards for the protocols, CMFEP, CMF, AC on little laminated index cards. I learned so much from him, and he was to me, great leaders and great mentors morph from things they do themselves to teaching other people, and whose brains have the ability of having the same dopamine shot when you see one of your fellows or young faculty present a wonderful study as you do. And your brain isn't saying, “I wish I was up there.” It's saying, “Isn't this so cool that this young man or woman or fellow or medical student is doing such a wonderful job?” And I had something to do with providing the soil for this seed to grow. That's the kind of guy he was. And so it was wonderful there.  And as I moved on, we got a new Chief of Medicine, Bill Hazzard. And I still hear from Bill on rare occasions, but Bill was one of the first geriatricians in the United States. He wrote the textbook, and his wish was that all the faculty and all the specialties get involved in a geriatric project. And so I had all those little index cards, and I looked and saw how many older people with metastatic breast cancer we'd given chemotherapy to. And these were little protocols, nothing like the protocols today, no 50-page consent forms, 50 pages of where your data is stored. They were like, here's the treatment, here's the dose mods. And I looked at those 70 patients with one of our residents, Kathy Christman, she may be retired now, but in any event, we wrote a paper and showed the old people did as well as the young with breast cancer. And we published it in JAMA. And it's one of the few papers in my career, I got no reviewers. They accepted the paper. I got no reviewers. So because I'm from Brooklyn, and my English is not what it should be, I had my friends read it to just make sure I didn't say anything egregious. But it got published and the next thing I know, my friends in medical oncology in the state were calling me. They said, “I got a 75-year-old woman here.” I'm saying, “Guys, I just wrote this paper. I really don't know anything about older people.” But slowly, with Bill Hazzard and others, I got more and more interested. I started reading about Geriatrics and I ended up making it a focal point of my career. It was kind of happenstance. And Bill was a wonderful mentor.  And then as I subsequently moved on, I worked with terrific people like Harvey Cohen, Lodovico Balducci, and Martine Extermann, all of them heavily involved with ASCO over the years as well, and B.J. Kennedy. They were wonderful to work with. And BJ was inspirational because BJ would get up at an ASCO meeting and he'd say when he saw the age cut off, he'd say, “How come you didn't let old people on that study? There'd be 1000 people in the audience.” And so he really was a great mentor. And I had the bittersweet opportunity of writing his obit for JCO years ago and kept up with his family a few years, but he was a wonderful man. Dave Johnson: I'm just reflecting on the fact that today, patient registries are sort of mainstream, but certainly in the ‘70s, ‘80s, even into the ‘90s, having a list of patients with a particular disorder seemed almost novel in many respects. And to have that was a godsend.  Dr. Hyman Muss: It was a godsend. I still remember those little file cards. And he called it the Oncology Research Center and it was a godsend. And you've got to remember, this is like ‘74, ‘75, it's a long time ago. Dave Johnson: So many of our listeners may not be as familiar with Wake Forest as they are with Duke and North Carolina, the other medical schools located there. But you were at right at a point where I mean, it was one of the top oncology programs in the country at that time. Still is, I don't mean to diminish it, but there was a who's who of people there at the time. And you were also involved in creating, I think, one of the first cooperative groups of sorts. It was the Piedmont Oncology Group. Tell us about that.  Dr. Hyman Muss: Oh, yeah, well, that brings back memories. So the NCI at that time wanted to get more, I think, rural and other smaller places involved in research. And they put out an RFA to form like regional cooperative groups. And we formed the Piedmont Oncology Association, the POA. We actually did well for a few years. We wrote some really good studies. We got one or two New England Journal articles. I worked with all the people, mainly in the community, community docs who would go on, and put people on the protocol. I mean, I looked at all the X-rays and scans in a lot of these patients myself as part of the studies we did. And it turned out to be a wonderful organization and it's still run today by Bayard Powell, who is one of our terrific fellows who's the head of Oncology at Wake Forest.  But after a while, we just couldn't compete with CALGB, of which I was a member of also, and ECOG and SWOG, even North Central Group, which was kind of formed in a similar venue, eventually merged. So we did a wonderful job for a while but the truth is we just didn't have the manpower to write studies for every disease site. So eventually we kind of petered out as a clinical trials group. But it's been maintained for educational programs and it's really served as a good resource for a lot of good education for the community oncologists who give most of the care in this country in the state. So it's been good. I think Pat kind of exceeded us with HOG, the Hoosier Oncology Group, which was in a similar vein. But it was a great experience and it was all Dr. Spurr, who thought of doing this and built it.  Dave Johnson: Certainly, it was inspirational in many people in and outside of Wake Forest. So with such an idyllic life, what in the world possessed you to move north to Vermont?  Dr. Hyman Muss: Well, you get this urgent life. You want to be a leader, you want to be a chief. Now, I tell younger people, if they love what they do, don't do it. So I got a wonderful opportunity at the University of Vermont to go up there and be Head of HemOnc. Chief of Medicine was a terrific guy, Burt Sobel. The university at that time, at one time it had a wonderful Oncology program. It had a federally funded cancer center with Irwin Krakoff and Jerry Yates, two other iconic guys. I don't know what the politics were but it had lost a tremendous amount of faculty, especially its clinical faculty, and they needed to rebuild it. And I went up and I thought, “Well, I'm in my 50s. This is going to be a great opportunity. If I don't do it now, I may never get the chance.” So I went up there and actually, it was a great opportunity. We hired terrific people. We got CALGB and we participated. We had actually a very good accrual for a small place and we had a very small but very effective cancer center. So it turned out to be a really good experience.  I worked with wonderful people. I recruited some wonderful people. But over time, the issues of the business of medicine, all the issues that happened, I'm saying I'm kind of losing my focus on clinical care and clinical trials, which I love to do. I don't need to tell either of you. I mean, Dave, you've been chief and department chair and Pat has run cancer centers. After a while, the administrative tasks just were so overwhelming and I didn't enjoy them, that I said, “I've got to get back in some type of more clinical focus.” And that's when I decided to look around and fortunately found what's turned out to be a dream job at UNC.  But it was a time of life. Maybe my ego got in the way of my logic. I don't regret it. I met and I think we rebuilt a wonderful clinical program. But you realize some of the resources of big places with-  we never had the research infrastructure to hire a lot of people and get big programs going on and great translational programs, just didn't have the funding. But it was great, and I have no regrets. And I learned how to tolerate the cold weather. And I have a lovely daughter, Sarah, who still lives up there. So we get back occasionally. And I've kept up with a lot of the people there. There are some wonderful people at UVM.  Pat Loehrer: From there, though, you were pulled down to North Carolina, where you've, again, built an incredible breast program there is outstanding. But you've created a Geriatric Oncology program, one of the first geriatric fellowships in oncology in the country. So tell us a little bit about that and what you feel may be your legacy is there at North Carolina.  Dr. Hyman Muss: Well, I had the opportunity over the years when I was at Wake, really, I got to know Shelley Earp, who's our cancer center director. I think maybe you were close to him, Pat. The longest surviving cancer center director on the planet, or among them. And we were good friends. And North Carolina's legislature actually gave the University of North Carolina substantial funding to improve cancer care in North Carolina, not just research. And so I had talked with Shelley about maybe moving, and because of the generosity of the state, really, he was able to really get me going, start a Geriatric Oncology program. And what I wanted to do was develop trials. As Dave says, I built a registry in 2009 here for older cancer patients using geriatric assessment. I have 2000 patients, which has been a resource for all types of faculty and fellows, and students to write papers. But I was able, with the support, to do things like this right from the get-go. And plus, I joined probably one of the best breast groups on the planet with Lisa Carey and Chuck Perou, and Larry, terrific people, Claire Dees. I had great luck in doing this, so I was able to really focus, get great support from my colleagues to build studies focusing on older people.  And then I had the great fortune of meeting Ned Sharpless, our prior NCI director. And Ned is one of the world's great aging biologists. And I don't mean aging as an adjective, he's really been a master on why we age, the biology of aging, cell senescence. So Ned taught me all about cell senescence and the mechanisms, especially the gene expression p16, which is like our own CDK inhibitor. And so I was able to start using his lab, collect samples, treat people with chemotherapy, follow them off with geriatric assessment. It was a great opportunity to do that here, and we got a lot of studies going and we showed what the pediatricians have known for years, that chemotherapy dramatically ages people, not just children, but adults. But it also allowed me to work with my colleagues in lymphoma and lung cancer to do little studies along the way.  And we eventually then built a T32 program. We got a T32, which we're kind of completing now our first five years to train oncology specialists in geriatrics. So the way we do it is they can be surgical oncologists, GU, we had a GYN oncologist, medical. With their HemOnc training, they do a year where they work with the geriatricians, so they go on geriatric inpatient service for a month and they really learn about older people. And part of it is a project. So we've been able to build that and develop a lot of programs with that. And I should say we've been very successful with mentorship and with ASCO support for things like YIAs, the late and great Arti Hurria, who absolutely an amazing woman. Some of her legacy at ASCO, the YIAs, and things. We've been successful in applying for some. So we've been able to build a whole spectrum of med and hematologists. We have an interest in Myeloma and AML focusing on older people. We've been able to build a whole team approach, including translational projects related to older people. And it's just been a great opportunity, and hopefully, my legacy here will be, too, and I'm working on it.  We have a wonderful guy, Bill Wood, who is very effective and has built this incredible coaching program to continue this legacy. Like many of us in this field, we are bothered because we all know the stats, we all know that first slide of the demographics of cancer, and yet it's been very hard in our culture to provide a lot of the services and build the clinical trials we need to best care for older people. It's still a major problem in this country. So as I cut back on my clinical care, I'm going to still advocate to try to improve the care of older people. Do geriatric assessment, build it into your clinical programs, get your hospitals to support you, convince them, build business plans, et cetera. And hopefully, that'll be my ultimate legacy, that we've made greater awareness of the older people, other than the usual stats, and we're really trying to care for them in a much more global sense, in a much more holistic sense than we've done. I hope we'll be successful. It's a slow haul, but we've got lots of great young people coming up through the pipelines, ASCO has been a great player in this. Many of you know people like Supriya Mohile and William Dale, Heidi Klepin, people, the next generation that's going to keep building this. So I hope the legacy will be that we get more buy-in, more interest, more trained people in other oncology-related subspecialties RadOnc, SurgOnc that will really focus on the care of older people. Dave Johnson: I don't think there's any doubt that that will be a part of your legacy Hy, but I think your legacy will be much broader than the world of geriatric oncology. Your mentorship leadership, your clinical skills, your educational capabilities, all of that will certainly last for many, many years in the future.  Well, I don't want to bring up a touchy topic, but you yourself are geriatric and we're wondering what your plans are for your semi-retirement. I recognize you're not retiring, but what do you like to do outside of medicine? Dr. Hyman Muss: I'll tell everybody who's interested in hearing this. On Tuesday, I had my 80th birthday.  Dave Johnson: Congratulations.  Dr. Hyman Muss: And I think I'm one of the most blessed guys. I'm pretty healthy. I married up -  my wife Loretta, who both of you, Pat Loehrer and Dave Johnson, know well.  Dave Johnson: Yeah, you definitely married up.  Dr. Hyman Muss: Yes. It's really carried me most of my life. She's great and so she flew up our three kids and we celebrated and I'm very fortunate. I have the enthusiasm and strength to do more clinical medicine. But I think the time has come for me to cut back my clinical medicine, so I'm going to do that in June. The hardest thing I've done is say goodbye to so many of my patients here.  We've been blessed. We have a lovely family. We're pretty close. I'm never bored, probably you two know well, I love to do things like fishing, outdoor stuff. I've really gotten into woodworking, so I'm not going to be bored. But there will be a small piece out of me when I walk out of that clinic in June. I know that and my two close psychiatry friends think it's going to really be a hard fall, but I don't think so. I still have some grants. In fact, I'm working with a fellow in City of Hope, Mina Sedrak, who's been very involved in ASCO, too. We are hoping to get an R01 looking at senolytic drugs that may prevent aging, and exercise in older women with breast cancer to see if we can reverse the trends of chemo. So my brain is still on that stuff, but the clinical care is going to be tough.  I had a note and for some reason, we talked about so many things. I wanted to mention that one of my great opportunities was joining the CALGB and then the Alliance and getting the support of Dr. Schilsky, Rich Schilsky, who's been one of the icons of ASCO to build cancer in the elderly working group with Dr. Harvey Cohen at Duke. And Harvey is one of the world's great geriatricians. And using that to get studies done, to incorporate studies with Arti Hurria on geriatric assessment, and really have it as a place where a lot of younger investigators could get started on a career in geriatric oncology. And that was really a great opportunity. It was kept on by Dr. Bertagnolli, who now is our NCI director, and I think was really the first group to really give good support for this. Dave Johnson: So we want to thank you very much for being our guest today.  We also want to thank our listeners of Oncology, Etc. This is an ASCO Educational Podcast where we talk about oncology medicine and much more. So if any of our listeners have an idea or a guest they would like for us to interview, please email us at education@asco.org. To stay up to date with the latest episodes and explore other educational content, visit ASCO's website at education.asco.org.   Thanks again for being our guest, Hy.  Dr. Hyman Muss: My pleasure. Thank you so much. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.  

Charles J. Yeo is a hepatopancreaticobiliary surgeon here at Jefferson. He was born in East Orange, New Jersey, and attended Spring Valley Senior High School in Spring Valley, New York. He received his undergraduate degree from Princeton University in 1975, summa cum laude with an A.B. in Biochemistry. Dr. Yeo graduated in 1979 from the Johns Hopkins University School of Medicine, being awarded the Upjohn Achievement Award and he was elected to Alpha Omega Alpha and Phi Beta Kappa. While completing his internship and residency in General Surgery at the Johns Hopkins Hospital, he pursued a one year Research Fellowship at the S.U.N.Y. Downstate Medical Center in Brooklyn, N.Y. Dr. Yeo joined the faculty of the Johns Hopkins University as an Instructor and Assistant Chief of Service in the Department of Surgery in 1985, and rose to the rank of Professor of Surgery in 1996. In 1997, he became a Professor in the Department of Oncology. Dr. Yeo directed the Pancreatic Cancer Interdisciplinary Working Group at Johns Hopkins, and served as the Surgical Clerkship Coordinator and Surgical Curriculum Consultant. In 2002, Dr. Yeo was named to an endowed chair at Johns Hopkins, becoming the inaugural John L. Cameron M.D. Professor for Alimentary Tract Diseases. On October 1, 2005 Dr. Yeo was named the 8th Samuel D. Gross Professor and he assumed the chairmanship of the Department of Surgery at Jefferson (now Sidney Kimmel) Medical College of Thomas Jefferson University in Philadelphia, Pennsylvania. He currently serves on the Board of Trustees of the Thomas Jefferson University Hospitals, and as the Senior Vice President and Chair of Enterprise Surgery for Jefferson Health (an 18 hospital system). Dr. Yeo has authored over 500 peer reviewed scientific papers, 105 book chapters, and over 15 books or monographs. Dr. Yeo is also known as the “Whipple King” having completed over 1700 Whipple procedures and treated 2100 patients with pancreatic and related cancers. Thank you so much Dr. Yeo for taking the time to speak with me.All proceeds from this episode go to Friends Against Pancreatic Cancer Fund and the Drs. Francis and Ernest Rosato Fund for Surgical Education and Research.___0:00 - Intro2:22 - What Is Hepato Pancreato Biliary Surgery?3:00 - Whipple Procedure9:13 - Treating Pancreatic Cancer14:15 - How Did You Become the Whipple King?17:14 - Navigating and Choosing Surgery in Med School25:57 - Residency32:41 - Memorable Experiences While at John Hopkins37:11 - Going Into Hepato Pancreato Biliary Surgery51:44 - An Average Day/Week as a Chair of Surgery56:40 - Best Thing About Being an HPB Surgeon58:52 - Worst Thing About Being an HPB Surgeon1:05:16 - Differences in Becoming the Chair of Surgery1:08:16 - Best Things About Working in Academia 1:10:28 - Characteristics of the Best Med Students/Residents1:11:26 - Maximizing Competitiveness Going Into Surgery1:14:10 - Favorite Historical Surgeon1:15:42 - Responsibility of Surgeons in Advocacy of Social Change1:17:30 - Advice for Graduating Med Students1:19:58 - Very Important Question!!!1:22:31 - Closing Message1:23:52 - Outro___ResourcesThe Smart Take from the Strong by Pete Carril - https://a.co/d/is7c0cN___View the Show Notes Page for This Episode for transcript and more information: zhighley.com/podcast___Connect With ZachMain YouTube: @ZachHighley Newsletter: https://zhighley.com/newsletter/Instagram: https://www.instagram.com/zachhighley/?hl=enWebsite: https://zhighley.comTwitter: https://twitter.com/zachhighleyLinkedln: https://www.linkedin.com/in/zach-highley-gergel-44763766/Business Inquiries: zachhighley@nebula.tv___Listen for FreeSpotify: https://open.spotify.com/show/23TvJdEBAJuW5WY1QHEc6A?si=cf65ae0abbaf46a4Apple Podcast: https://podcasts.apple.com/us/podcast/the-zach-highley-show/id1666374777___Welcome to the Zach Highley Show, where we discuss personal growth and medicine to figure out how to improve our lives. My name is Zach and I'm a medical student, and soon to be physician, in Philadelphia. Throughout these episodes I'll interview top performers from around the world in business, life, and medicine in hopes of extracting the resources and techniques they use to get to the top.The best way to help the show is share episodes on any platform. If you think a friend or family member will like a certain episode, send it to them!See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

April is Occupational Therapy Appréciation month and this week we will feature the amazing OTs from the Marine Park JAG-ONE Physical Therapy Office in Brooklyn, NY. Join the conversation as Maxcita, Krista, Esther share about our experience as Downstate Medical Center alumni, why being a certified hand therapist is so important, how mental health plays a part in the healing process, and a few tips on injury prevention. As an Occupational Therapist specializing in Hand Therapy practice Maxcita Alverez's absolute passion has been to increase her patients' awareness/knowledge of their injuries.  Through understanding we are able to capture purpose and work harder to achieve goals. Patient education is essential in ensuring compliance and improvement.  Her growth as a clinician has been inspired by the most amazing group of therapists and physicians who have mentored and educated her through their outstanding and exemplary work.  Each day, Maxcita works to motivate and inspire her patients to do more than the day before.  She incorporates her patients' unique experiences, goals and purpose, as she works together with each individual patient to get them back to performing their daily life skills, while regaining mobility and strength.  Maxcita has worked throughout various hospitals/ settings including: St. Vincents/Mt Sinai Hospital, Private Practice and Outpatient Therapy. She's also a Downstate Alumni and the NY Lead Occupational Therapist for JAG-ONE Physical Therapy. Krista Denaro is a licensed occupational therapist and recent graduate from SUNY Downstate. Her time at Jag One Physical Therapy dates back to 2016 where she was a volunteer and OT aide in hand therapy. Her interest in hand therapy continued as she completed her Fieldwork level 2 working under Maxcita leading to her current employment at JAG-ONE. Krista strives to work with each patient using a client-centered approach by understanding their needs and values while incorporating a unique plan of care that mirrors their daily activities. Her goal is to become a certified hand therapist as well as continue to expand her practice and knowledge to educate and rehabilitate her patients. Esther Milina graduated from SUNY Downstate Medical Center with a Master's in Occupational Therapy in 2019. Esther completed her Fieldwork Level 2 placement with Maxcita Alvarez and which led to her career at JAG-ONE in 2020.  Esther is a Graston Technique provider, kinesotape provider and certified in LSVT-BIG. Esther is committed to serving her communities in South Brooklyn where she grew up and is fluent in Russian. She prides herself on use of humor in order to build relationships with her patients and assist them in reaching their goals. She is currently studying to achieve her goal of becoming a certified hand therapist. For more information about the Marine Park office visit www.jagonept.com. --- Send in a voice message: https://podcasters.spotify.com/pod/show/bemoretoday/message Support this podcast: https://podcasters.spotify.com/pod/show/bemoretoday/support

Dr. Stanley Plotkin, MD ( https://en.wikipedia.org/wiki/Stanley_Plotkin ), is an American physician, scientist, and scholar, who in the 1960s, while working at Wistar Institute in Philadelphia, played a pivotal role in discovery of a vaccine against rubella virus (which is now used worldwide as a key component of the MMR vaccine), and has worked extensively on the development and application of a wide range of other vaccines including those for polio, rabies, varicella, rotavirus and cytomegalovirus ( https://www.epiv.eu/ ). Dr. Plotkin graduated from New York University in 1952 and obtained a medical degree at Downstate Medical Center in Brooklyn. He was a resident in pediatrics at the Children's Hospital of Philadelphia and at the Hospital for Sick Children in London. In 1957, Dr. Plotkin served in the Epidemic Intelligence Service of the Centers for Disease Control (CDC) of the U.S. Public Health Service for three years and then served as a member of Wistar's active research faculty from 1960 to 1991. Today, in addition to his emeritus appointment at Wistar, Dr. Plotkin is emeritus professor of Pediatrics at the University of Pennsylvania ( https://www.med.upenn.edu/apps/faculty/index.php/g275/p1554 ), and works as a consultant advising vaccine manufacturers, biotechnology firms, non-profits and governments. Dr. Plotkin's book, Vaccines, remains the standard reference on the subject. He is also an editor with Clinical and Vaccine Immunology, which is published by the American Society for Microbiology in Washington, D.C. Support the show

Before he would become arguably one of the most popular members of hip-hop's newest collective known as “41” -- the rapper TaTa was born Zaire Tasean Rivera on February 17th, 2005 in the Downstate Medical Center in Brooklyn, New York. Born to his mother, Joniqua Alvarez and his father, Zaire Rivera, Zaire Jr. was raised in a Puerto Rican and Panamanian family alongside three brothers, Zyon, King, and Prince, as well as one sister, Laila. Together, these four spent the vast majority of their youth growing up on the streets of Brownsville in Brooklyn. As a kid, Zaire's early life was pretty rudimentary. He used to fill his hours by playing basketball in the park and then picking up a controller and gaming well into the night. He also had a deep-seated passion for music, looking up to a number of hip-hop icons including Drake, A Boogie Wit da Hoodie, and Lil Wayne. His infatuation with these rappers' skill sets would lead to Zaire trying his hand at writing rap lyrics of his own from a young age -- but he didn't concentrate on music as much as he might have liked to at first because he also had to focus on his education.

Poet and short story writer Maya Mitra Das was born in India and came to the U.S. in 1973. She studied internal medicine and pediatrics in India, England and the United States, earning her M.D. and Ph.D. She received her training at Downstate Medical Center and State University Hospital in Brooklyn, New York.   Book: Rhythms Primeval

On today's show we speak to allergist, Dr. Payel Gupta about penicillin allergy.  Dr. Gupta is triple board certified in Allergy & Immunology, Pediatrics and Internal Medicine and currently has a practice at Ease Allergy in Brooklyn.  We discuss how common penicillin allergy is and how commonly the diagnosis is incorrect.  She goes through the four types of hypersensitivity reaction, and then focus in on type I, the IgE-mediated reaction.  We go through presentation, treatment, and some commonly confused conditions.  She teaches us how penicillin testing is done, why we can trust it and dispels some misconceptions about penicillin allergy. Dr. Gupta earned her medical degree from Michigan State University; and then pursued a residency in both Internal Medicine and Pediatrics at Rush University Medical Center in Chicago. She then moved to New York City where she completed a fellowship in Allergy and Immunology at the State University of New York, Downstate Medical Center. She is currently on the board of the New York Allergy and Asthma Society and serves as the treasurer/ secretary.  She is also a National Spokesperson for the American Lung Association. Find her practice at easeallergy.com, her podcast at itchpodcast.com and follow her on Instagram @nycdoctor. Find this and all episodes on your favorite podcast platform at PhysiciansGuidetoDoctoring.com Please be sure to leave a five-star review, a nice comment and SHARE!!!

Stāsta Latvijas Zinātņu akadēmijas prezidents Ivars Kalviņš Vai zini, kāda ir vismazākā zāļu molekula pasaulē, par kuras bioloģiskās iedarbības izpēti piedevām vēl ir piešķirta Nobela prēmija? Atbilde uz šo jautājumu meklējama 1987. gadā, kad, pētot asinsspiediena regulācijas mehānismus, fiziologs Roberts Frensiss Fērgots (Robert Furchgott) no Ņujorkas Downstate Medical Center kopā ar savu studentu Džonu Zavadzki (John Zawadzki)  atklāja, ka, atbildot uz smadzeņu raidītajiem signāliem, asinsvadu sieniņas no iekšpuses izklājošās šūnas, kuras sauc par endotēlija šūnām, veido nezināmu signālmolekulu, kas liek atslābt asinsvadu sieniņu gludajai muskulatūrai. Tā rezultātā asinsspiediens samazinās, bet asins plūsma palielinās. Viņiem pašiem gan neizdevās noskaidrot, kas tā īsti ir par vielu, toties citi zinātnieki atcerējās, ka jau 1977. gadā Ferids Murads (Ferid Murad) no Teksasas universitātes Medicīnas skolas bija noskaidrojis, ka labi zināmās sirdszāles nitroglicerīns organismā tiek noārdīts līdz NO jeb slāpekļa monoksīdam, kam seko sirds asinsvadu atslābināšanās. Un tā zinātnieku grupa Luisa Ignarro (Louis Ignarro) vadībā no Losandželosas Kalifornijas Universitātes Medicīnas skolas un Salvadora Monkadas (Salvador Moncada) vadītie pētnieki no Wellcome Research Laboratories (Bekenhema, Lielbritānija) 1987. gada janvārī praktiski vienlaicīgi nopublicēja savu pētījumu rezultātus, kas pierādīja, ka šī noslēpumainā signālmolekula Fantomas nav nekas cits kā labi zināmais slāpekļa monoksīds! Šī divu atomu molekula mūsu audos un asinīs dzīvo nedaudz ilgāk par piecām sekundēm, taču pa šo laiku paspēj iespiesties muskuļaudu šūnās un palaist reakciju kaskādi, kas beidzas ar asinsvadu muskuļaudu atslābināšanos. Par šiem pētījumiem Ferids Murads, Roberts Fērgots un Luiss Ignarro 1998. gadā tika apbalvoti ar Nobela prēmiju. Šobrīd NO ir mazākā molekula pasaulē, kura ir atzīta un tiek lietota kā medikaments. Šīs zāles gāzveida formā lieto tādu zīdaiņu ārstēšanai, kam ir kritiski paaugstināts asinsspiediens plaušās.  Vēlāk tika noskaidrots, ka slāpekļa monoksīdam ir milzīga nozīme daudzu jo daudzu citu fizioloģisko procesu regulēšanā organismā. Izrādījās, ka šī molekula ir nervu signālu pārnesēja arī mūsu smadzenēs un ir iesaistīta atmiņas procesos. Smadzeņu uzbudinājuma laikā to sintezē ap 5% neironu un tiem NO nav bīstams. Savukārt 95% pārējo neironu ir ārkārtīgi jūtīgi pret paaugstinātu NO koncentrāciju, kas tos var pat nogalināt. Ar šo fenomenu mēs varam izskaidrot cilvēka sajukšanu prātā pārlieku lielu pārdzīvojumu rezultātā. Arī vispārējo ievērību guvušā medikamenta Sildenafila (plašāk pazīstams kā Viagra) , darbības pamatā ir tieši NO izsauktās ķīmiskās pārvērtības. Vēl viens NO darbības aspekts ir tā spēja kontrolēt trombu veidošanās procesus organismā. Un it kā ar to vēl nebūtu gana, atklājās, ka arī cilvēka imūnsistēmas šūnas spēj ražot NO, ar kuru palīdzību tās spēj nogalināt vēža šūnas, baktērijas un vīrusus. Kad sākās Covid-19 pandēmija, tieši Luiss Ignarro iniciēja klīniskos pētījumus par NO inhalācijas lietošanu Covid-19 slimnieku ārstēšanā. Cerams, ka šie pētījumi pavērs jaunu lappusi stāstā par NO brīnumainajiem efektiem, kuriem pateicoties, 1992. gadā šī molekula tika atzīta par Gada molekulu pasaulē.

Dr. Susana Martinez-Conde and Dr. Stephen Macknik are neuroscientists who specialize in the science of magic and illusion. Both are professors of ophthalmology, neurology, and physiology & pharmacology at the Downstate Medical Center. Together they pioneered the study of various aspects of magic such as perception, cognitive illusion, and attentional misdirection. On this episode, we discuss how magic tricks fool the brain, why everyday life is an illusion, what neuroscientists and magicians can learn from each other and much more. FitMind Neuroscience-Based App: http://bit.ly/afitmind Website: www.fitmind.co Show Notes 0:00 | Intro to Stephen Macknik, PhD & Susana Martinez-Conde, PhD 8:00 | How Magic Hacks Our Minds 13:00 | What Neuroscientists Learn from Magicians 15:54 | What Magicians Learn from Neuroscientists 17:24 | Testing Attention Manipulation  22:25 | Cognition & Calculation 25:36 | How Our Brains Construct Reality 28:27 | Vision Produces Our Changing Realities 29:53 | Microsaccades Explained 32:58 | Brain on Autopilot 35:50 | Expertise as an Unconscious Process 40:46 | Magic for Kids vs. Magic for Adults 43:43 | Is Magic Still Enjoyable When You Know the Tricks? 48:24 | Rapid Fire Questions

RHYTHMS PRIMEVAL by Maya Mitra DasThe verses of Maya Mitra Das plumb the alchemy of primeval moons and mist-wrapped mountains; delving deep into the realm of personal myth. Spanning the arc of ecstasy and despair, her poems explore the boundaries of human loneliness as well as the healing power of love.Poet and short story writer Maya Mitra Das was born in India and came to the U.S. in 1973. She studied internal medicine and pediatrics in India, England and the United States, earning her M.D. and Ph.D. She received her training at Downstate Medical Center and State University Hospital in Brooklyn, New York.She completed two fellowships-one for the department of hematology on oncology at U.C.L.A. Medical Center and the second at University of California San Francisco for radiation oncology. She currently serves on the medical staff at Children's hospital on Oakland, California working with sickle cell anemia in children. Among her many hobbies, Maya performs 'Bharatanatyam' Indian classical dance.Her poetry has appeared in her book Rhythms Primeval, the anthology Tuesday's Poetry, and two narrative poems have been anthologized in What's in a Name. Her fiction has appeared her full-length collection of short stories Silhouettes of Time, and in the anthologies Tremors: Short Fiction by California Writers and Insight, Hindsight & Flights of Fancy. She has also authored several scientific publications.https://www.amazon.com/Rhythms-Primeval-Maya-Mitra-Das/dp/1943471215https://www.authormayamitradas.com/http://www.bluefunkbroadcasting.com/root/twia/mmdas2ec.mp3   

RHYTHMS PRIMEVAL by Maya Mitra DasThe verses of Maya Mitra Das plumb the alchemy of primeval moons and mist-wrapped mountains; delving deep into the realm of personal myth. Spanning the arc of ecstasy and despair, her poems explore the boundaries of human loneliness as well as the healing power of love.Poet and short story writer Maya Mitra Das was born in India and came to the U.S. in 1973. She studied internal medicine and pediatrics in India, England and the United States, earning her M.D. and Ph.D. She received her training at Downstate Medical Center and State University Hospital in Brooklyn, New York.She completed two fellowships-one for the department of hematology on oncology at U.C.L.A. Medical Center and the second at University of California San Francisco for radiation oncology. She currently serves on the medical staff at Children's hospital on Oakland, California working with sickle cell anemia in children. Among her many hobbies, Maya performs 'Bharatanatyam' Indian classical dance.Her poetry has appeared in her book Rhythms Primeval, the anthology Tuesday's Poetry, and two narrative poems have been anthologized in What's in a Name. Her fiction has appeared her full-length collection of short stories Silhouettes of Time, and in the anthologies Tremors: Short Fiction by California Writers and Insight, Hindsight & Flights of Fancy. She has also authored several scientific publications.https://www.amazon.com/Rhythms-Primeval-Maya-Mitra-Das/dp/1943471215https://www.authormayamitradas.com/http://www.bluefunkbroadcasting.com/root/twia/mmdasec.mp3   SILHOUETTES OF TIME by Maya Mitra DasThese intriguing tales by Maya Mitra Das take us on wildly imaginative journeys to exotic and sometimes alien landscapes -- introducing us to infinitely curious moments in time, space and memory. Maya's poetry and fiction have appeared in numerous anthologies. This is her first collection of short fiction.https://www.amazon.com/Silhouettes-Time-Maya-Mitra-Das/dp/194347107Xhttps://www.authormayamitradas.com/http://www.bluefunkbroadcasting.com/root/twia/mmdasec.mp3   

Scott Abramson joined Northern California Kaiser Permanente in July 1979 where (as of July 2016,) he has been on Neurology staff for the last 37 years. He did his Residency in Neurology and Neurophysiology at Downstate Medical Center in Brooklyn N.Y. He attended medical school at University of Georgia in Augusta. He did undergraduate training at Cornell University, and graduated high school from the illustrious Georgia Military Academy in College Park, Georgia. For over 20 years Dr. Abramson had been passionately involved in the communication and physician wellness projects at Kaiser Permanente where he has been on the regional board of physicians for these endeavors. He has delivered dozens of workshops in this arena and personally coached scores of physicians and staff. He has written and developed programs on time management, physician to patient communication, physician to physician communication, and staff to physician communication. Dr. Abramson also writes a monthly column on communication issues and physician health and wellness that is online available to all Kaiser physicians. He has delivered Grand rounds to various audiences on such topics as professional satisfaction, teamwork, difficult conversations, presentation skills, and his favorite, “The Secret of Happiness.” In 1982, Dr. Abramson was awarded the Physician of the Year honor in his medical facility. In 2003 he was given Teaching Excellence Award from Physician Education, and in 2010 was nominated as a Kaiser Hero for his work in regional physician communication. On a personal note, Dr. Abramson has been a longtime volunteer at the Samaritan House Medical Clinic in San Mateo, Ca. helping provide medical care for the indigent of that county. He has also been a longtime volunteer at the USO, helping to provide rest and respite to the young men and women in our armed forces. Dr. Abramson lives with his wife Pamela of 38 years in San Mateo Ca. They have 2 sons, Jonathan living in Spokane, Washington who is involved in movie business, and Jeremy who graduated University of Oregon, now living in Miami, working in the Sports training field.   Unlock Bonus content and get the shows early on our Patreon Follow us or Subscribe: Apple Podcasts | Google Podcasts | Stitcher | Amazon  | Spotify --- Show notes at https://rxforsuccesspodcast.com/61 Report-out with comments or feedback at https://rxforsuccesspodcast.com/report Music by Ryan Jones. Find Ryan on Instagram at _ryjones_, Contact Ryan at ryjonesofficial@gmail.com

Addiction is a treatable disease, but how can people differential between quality care and fraud? Dr. Rosenthal dispels the truth on quality treatment. Mitchell S. Rosenthal, MD Mitchell S. Rosenthal, M.D., the founder of Phoenix House, one of the nation's leading non-profit substance abuse treatment organizations, is president of the Rosenthal Center for Addiction Studies. The Center plays an increasingly significant role in the treatment field, providing a valuable platform for advocacy and the formulation of public policy. Its surveys, investigations, publications, and substantial presence on the Internet provides critical information on substance abuse issues to policymakers, healthcare professionals as well as families and individuals coping with addiction. Dr. Rosenthal has served as a White House advisor on drug abuse, a special consultant to the Office of National Drug Control Policy, chairman of the New York State Advisory Council on Drug Abuse, and president of the American Association of Psychoanalytic Physicians. He is a lecturer in psychiatry at Columbia University's College of Physicians and Surgeons. Dr. Rosenthal is a psychiatrist whose research, clinical skills, and advocacy have produced model treatment protocols, widely replicated throughout the country and abroad. His pioneering efforts in substance abuse treatment date from his work at the U.S. Naval Hospital in Oakland, California (1965-1967), where he formed the first service-sponsored therapeutic community for the treatment of addiction. As deputy commissioner of New York City's Addiction Services Agency, he created the Phoenix House citywide network of treatment facilities in 1967. In 1972, he resigned his city post to become president of the now independent Phoenix House Foundation and oversee the national expansion of its treatment and prevention services over the following three and a half decades. Dr. Rosenthal earned his B.A. from Lafayette College and his M.D. from the State University of New York's Downstate Medical Center. He is a member of the Council on Foreign Relations, deputy chair of the National Council on Alcoholism and Drug Dependence, and serves on the board of the Partnership for Drug Free Kids and Delancey Street Foundation.

Miriam R. Lieberman, MD, FAAD, is a board-certified dermatologist who specializes in medical and cosmetic dermatology for adults and children. Dr. Lieberman received her medical degree and completed her residency training in dermatology at the State University of New York, Downstate Medical Center. Dr. Lieberman is committed to quality patient care with a high priority on health education and preventative wellness. This podcast is powered by JewishPodcasts.org. Start your own podcast today and share your content with the world. Click jewishpodcasts.fm/signup to get started.

Miriam R. Lieberman, MD, FAAD, is a board-certified dermatologist who specializes in medical and cosmetic dermatology for adults and children. Dr. Lieberman received her medical degree and completed her residency training in dermatology at the State University of New York, Downstate Medical Center. Dr. Lieberman is committed to quality patient care with a high priority on health education and preventative wellness.

Saison 2, épisode spécial #6 : Le coronavirus aux États-Unis (New York). Paroles de soignant. Depuis le début de l'épidémie de COVID-19, la terre entière met à l'honneur ses professionnels de santé. Alors, nous nous sommes demandées : Comment les soignants vivent ce quotidien et gèrent-ils l'afflux de patients ailleurs qu'en France ? Comment leur pays s'est-il organisé pour faire face à cette crise sanitaire ? Qu'est-ce qui est différent par rapport à la lutte française ? On pose nos valises (virtuelles bien sûr) aux 4 coins du Monde. Et on rencontre des soignants francophones qui nous parlent de la situation dans leur pays. Pour cette 5ème et dernière escale, rendez-vous à New York ! Nous donnons la parole au Dr Julien Cavanagh, neurologue au sein de l’hôpital universitaire Downstate Medical Center, à Brooklyn. Le Dr Cavanagh nous explique la situation au coeur de l’épidémie aux États-Unis, notamment à New York. Il aborde de nombreux sujets, comme l’approvisionnement, la solidarité et parle de certaines réalités, parfois difficiles, que cette pandémie mondiale a dévoilée. Bonne écoute ! ⁠Merci à Nathan Marécaux pour l'aide au montage. Ainsi qu'à Bastien Marécaux pour le visuel. Merci à @10deDer pour la musique.

Ira Pastor, ideaXme life sciences ambassador, interviews Dr. Stanley Plotkin, Professor Emeritus at both Wistar Institute and the University of Pennsylvania and consultant to the vaccine industry. Ira Pastor Comments: So as we sit here a few months into the global Covid-19 pandemic, one big question on everyone’s mind is when will we see the first mass produced vaccine against this current strain, especially as it looks like in the United States there will be some loosening of quarantine / "shelter in place" rules to re-start the economy. Dr. Stanley Plotkin: Dr. Stanley Plotkin is an American physician, scientist, and scholar, in many circles referred to as “the Godfather of Vaccines", who in the 1960s, while working at Wistar Institute in Philadelphia, played a pivotal role in discovery of a vaccine against Rubella virus (also known as German measles or three-day measles), which is now used worldwide (as a key component of the MMR vaccine - a combination vaccine also that protects against measles and mumps) and has worked extensively on the development and application of a wide range of other vaccines including polio, rabies, varicella, rotavirus and cytomegalovirus. Dr. Plotkin graduated from New York University in 1952 and obtained a medical degree at Downstate Medical Center in Brooklyn. He was a resident in pediatrics at the Children’s Hospital of Philadelphia and at the Hospital for Sick Children in London. In 1957, Dr. Plotkin served in the Epidemic Intelligence Service of the Centers for Disease Control (CDC) of the U.S. Public Health Service for three years, and then served as a member of Wistar’s active research faculty from 1960 to 1991. Today, in addition to his emeritus appointment at Wistar, he is also Professor Emeritus of Pediatrics at the University of Pennsylvania, and works as a consultant to vaccine manufacturers, such as Sanofi Pasteur, as well as biotechnology firms, non-profits and governments. Dr. Plotkin's book, "Vaccines", remains the standard reference on the subject. Dr. Plotkin is also an editor with Clinical and Vaccine Immunology, which is published by the American Society for Microbiology in Washington, D.C. On this episode we will hear from Dr. Plotkin: About his background; how he became interested in medicine, research, and how after joining Wistar (under the equally famous Dr. Hilary Koprowski), and working for a bit with Anthrax, how Rubella became a target of interest, His thoughts on Covid-19: how worried / concerned / optimistic he is about vaccine development. How with dozens of coronavirus vaccine candidates being developed, in various companies and organizations (including RNA vaccines, DNA vaccines, single protein vaccines, multiple protein vaccines, etc.) how a choice is made of which "to go with" once some are approved. About the requirement for a "perfect vaccine" with 100% coverage, versus less perfect vaccines that could get to market earlier. The topics of Plant BioTechnology, edible vaccines and the Anti-Vaccine movement. Credits: Ira Pastor interview video, text, and audio. Follow Ira Pastor on Twitter:@IraSamuelPastor If you liked this interview, be sure to check out ourinterview with Dr. Linfa Wang: Hunting Down Covid-19 and Other Deadly Diseases! Follow ideaXme on Twitter:@ideaxm On Instagram:@ideaxme Find ideaXme across the internet including on iTunes,SoundCloud,Radio Public, YouTube, TuneIn Radio,I Heart Radio, Google Podcasts, Spotify and more. ideaXme is a global podcast, creator series and mentor programme. Our mission: Move the human story forward!™ ideaXme Ltd.

Aux Etats-Unis, le coronavirus se propage à un rythme effrayant avec déjà des centaines de milliers de personnes contaminées et plusieurs milliers de morts. En attente d'un traitement efficace, les médecins donnent tout pour sauver leurs patients. Julien Cavanagh, neurologue français et chef des internes dans un hôpital de New York, raconte à Twenty Twenty comment il prend soin de ses malades chaque jour plus nombreux. La chloroquine, objet des plus vives polémiques, est-elle LE remède miracle ? Dans cet épisode, décryptage avec nos journalistes santé Ivan Couronne et Julie Charpentrat. Invités : Julien Cavanagh, neurologue et chef des internes au Downstate Medical Center à New York Ivan Couronne, journaliste spécialiste des questions de science et de santé à Washington Julie Charpentrat, journaliste au service fact-checking et spécialiste science et santé

On today’s show we speak to allergist, Dr. Payel Gupta about penicillin allergy.  Dr. Gupta is triple board certified in Allergy & Immunology, Pediatrics and Internal Medicine and currently has a practice on the Upper West Side of Manhattan with ENT and Allergy Associates.  We discuss how common penicillin allergy is and how commonly the diagnosis is incorrect.  She goes through the four types of hypersensitivity reaction, and then focus in on type I, the IgE-mediated reaction.  We go through presentation, treatment, and some commonly confused conditions.  She teaches us how penicillin testing is done, why we can trust it and dispels some misconceptions about penicillin allergy. Dr. Gupta earned her medical degree from Michigan State University; and then pursued a residency in both Internal Medicine and Pediatrics at Rush University Medical Center in Chicago. She then moved to New York City where she completed a fellowship in Allergy and Immunology at the State University of New York, Downstate Medical Center.    She is currently on the board of the New York Allergy and Asthma Society and serves as the treasurer/ secretary.  She is also a National Spokesperson for the American Lung Association. Find her podcast at itchpodcast.com and follow her on Instagram @nycdoctor. Find this and all episodes on your favorite podcast platform at PhysiciansGuidetoDoctoring.com Please be sure to leave a five-star review, a nice comment and SHARE!!!

This week, we're presenting stories about what happens when our expectations don't match up with reality. Part 1: Married neuroscientists Susana Martinez-Conde and Stephen Macknik are surprised by what they learn when they investigate deception at a psychic convention. Part 2: While working in the South Sudan, OB-GYN Africa Stewart must wait for an elder's permission before treating a pregnant woman gored by a bull. Susana Martinez-Conde and Stephen Macknik are award-winning neuroscientists and professors at the State University of New York, Downstate Medical Center. They are best known for their studies on perception, illusions, and attentional misdirection in stage magic. They produce the annual Best Illusion of the Year Contest, now in its 13th edition, and are the authors of the international bestseller Sleights of Mind: What the Neuroscience of Magic Reveals About Our Everyday Deceptions. Their new book, Champions of Illusion: The Science Behind Mind-Boggling Images and Mystifying Brain Puzzles, comes out October 24th.    Dr. Africa Stewart graduated with honors from Johns Hopkins University in 1995 with a BA in psychology and mathematical science. She then attended Drexel University Medical School in Philadelphia. In 1999 she completed a Masters of Business Administration with a concentration in Strategic Planning from the University of Pittsburgh's Katz School of Business. She then returned to Philadelphia to finish her medical training at Drexel. In 2000 she received a Doctorate in Medicine and began Obstetrics and Gynecology residency at Hahnemann University Hospital. Her career with MSF began in Sudan in June 2011. Dr. Stewart has completed 4 surgical field missions and served as a guide for the Forced From Home exhibit in 2016. She currently serves on the Board of Directors for Doctors Without Borders and continues to support women’s health care locally and abroad with and emphasis on education and prevention. Learn more about your ad choices. Visit megaphone.fm/adchoices

For our first rounds in 2018, we welcome Dr. Gayatri Devi, a neurologist and graduate of the Narrative Medicine program at Columbia, who will speak about her book The Spectrum of Hope: An Optimistic and New Approach to Alzheimer’s Disease and Other Dementias (Workman, 2017). Imagine finding a glimmer of good news in a diagnosis of Alzheimer’s. And imagine how that would change the outlook of the 5 million Americans who suffer from Alzheimer’s disease and other dementias, not to mention their families, loved ones, and caretakers. A neurologist who’s been specializing in dementia and memory loss for more than 20 years, Dr. Gayatri Devi rewrites the story of Alzheimer’s by defining it as a spectrum disorder—like autism, Alzheimer’s is a disease that affects different people differently. She encourages people who are worried about memory impairment to seek a diagnosis, because early treatment will enable doctors and caregivers to manage the disease more effectively through drugs and other therapies. Told through the stories of Dr. Devi’s patients, The Spectrum of Hope is the kind of narrative medical writing that grips the reader, humanizes the science, and offers equal parts practical advice and wisdom with skillful ease. There are chapters on how to maintain independence and dignity; how to fight depression, anxiety, and apathy; how to communicate effectively with a person suffering from dementia. Plus chapters on sexuality, genetics, going public with the diagnosis, even putting together a bucket list—because through her practice, Dr. Devi knows that the majority of Alzheimer’s patients continue to live and work in their communities. Gayatri Devi, MD, MS, FACP, FAAN, is Director of the New York Memory and Healthy Aging Services and an attending physician at Lenox Hill Hospital/Northwell Health and a Clinical Professor of Neurology at Downstate Medical Center. She is a board certified neurologist, with additional board certifications in Pain Medicine, Psychiatry, and Behavioral Neurology, and she served on the faculty of New York University’s School of Medicine as Clinical Associate Professor of Neurology and Psychiatry until 2015. She is the author of over 50 publications in peer-reviewed journals on the topic of memory loss, as well as the books Estrogen, Memory and Menopause, What Your Doctor May Not Tell You About Alzheimer’s Disease, and A Calm Brain. She lives and practices in New York City.

In this episode of the Jewish Sacred Aging Podcast, Rabbi Address has a conversation with Dr. Don Friedman, a retired rheumatologist and faculty member at the Sidney Kimmel School of Medicine at Thomas Jefferson University in Philadelphia. About Dr. Friedman: Donald M. Friedman M.D. received his undergraduate A.B. degree from Princeton University in 1966 and his M.D. from The University of Pennsylvania School of Medicine in 1970.  He was trained in Internal Medicine at Rhode Island Hospital in Providence, RI and Hahnemann Hospital in Philadelphia, PA.  Following his Medical Internship and Residency, he did a Fellowship in Medical-Psychiatric Liaison at Downstate Medical Center in Brooklyn, NY where he learned about the emotional aspects of medical illness. He was also a Fellow in Rheumatology at Temple University Hospital where he was trained to treat arthritis, and musculoskeletal and collagen diseases. For more than twenty five years, Dr. Friedman was Chief of the Section of Rheumatology at Crozer-Chester Medical Center, a large community teaching hospital in suburban Philadelphia.  He is Board Certified in Rheumatology and Internal Medicine. Since retiring from medical practice, Dr. Friedman has been interested in Spirituality and Healthcare and has taken courses at Harvard Medical School in the Benson-Henry Institute for Mind Body Medicine and at the George Washington Institute of Spirituality and Health.  He completed a workshop program on SoulCare in HealthCare at The Omega Institute with Drs. Joan Borysenko and Gordon Dverin.  He currently teaches courses in Professionalism, Introduction to Clinical Medicine, and the Healer's Art at Jefferson Medical College in Philadelphia, PA. Recording and post-production services for the podcasts is provided by the Professional Podcasts division of The Lubetkin Media Companies, which also manages this website. Now, you can subscribe to an RSS feed for either of Rabbi Address' podcast series separately. Subscribe to the RSS feed for the Jewish Sacred Aging podcasts.   Subscribe to the RSS feed for Boomer Generation Radio podcasts.     Subscribe to both of these podcast series in the Apple iTunes Music Store. [spp-optin]

Alan Phillips, J.D. (www.vaccinerights.com) is the only attorney in the U.S. whose practice is focused solely on vaccine exemptions and waivers. He advises individuals, families, attorneys, groups and organizations throughout the U.S. on vaccine exemption and waiver rights; supports legislative initiatives aimed at expanding vaccine freedom of choice; is published internationally on vaccine health and legal matters; has appeared at rallies, conferences throughout the U.S., and hosts two weekly radio shows discussing vaccine rights issues. Alan is also a regularly featured writer for Natural News, GreenMedInfo.com, Liberty Roundtable, and the Pastoral Medical Association. Dr. Rebecca (Roczen) Carley received her Bachelor's degree in Diagnostic Ultrasound, attended medical school (and received the Samuel L. Kountz award for clinical excellence in surgery at graduation), and trained to be a general surgeon at State University of New York at Downstate Medical Center in Brooklyn. Dr. Carley also worked as an attending Emergency Room physician at Kings County Medical Center in Brooklyn (which is the primary training affiliate for Downstate students), and is the largest hospital (and busiest trauma center) in the United States. In recent weeks, we have witnessed the roll out of a massive promotion of vaccination by government, media and their partner corporations in the U.S. and elsewhere. The clear goal is a massive increase in the number of vaccines being administered to the public and especially to children, the demonization of those who choose to avoid vaccines, the goal of forced vaccination, and the increasingly common suggestion that those who question the religion of vaccination "science" should be put in prison for daring to question its validity.

Alex welcomes to the show Dr. Rebecca Carley, a former general surgeon at State University of New York at Downstate Medical Center in Brooklyn and host of the “What’s Ailing America” radio show. Dr. Carley talks with Alex about the dangers of vaccines.

Alex welcomes to the show Dr. Rebecca Carley, a former general surgeon at State University of New York at Downstate Medical Center in Brooklyn and host of the “What’s Ailing America” radio show. Dr. Carley talks with Alex about the dangers of vaccines.

Alex welcomes to the show Dr. Rebecca Carley, a former general surgeon at State University of New York at Downstate Medical Center in Brooklyn and host of the “What’s Ailing America” radio show. Dr. Carley talks with Alex about the dangers of vaccines.